ArticleContemporary clinical trials communications2019

First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427).

Toan Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.